These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon. Flavahan NA Rheum Dis Clin North Am; 2008 Feb; 34(1):81-7; vii. PubMed ID: 18329534 [TBL] [Abstract][Full Text] [Related]
7. Iontophoretic evaluation of vascular reactivity to acetylcholine in patients with primary Raynaud's phenomenon and systemic sclerosis. Marasini B; Conciato L Clin Rheumatol; 2001; 20(6):451-2. PubMed ID: 11771535 [No Abstract] [Full Text] [Related]
8. Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma. Freedman RR; Girgis R; Mayes MD J Rheumatol; 2001 Jan; 28(1):119-21. PubMed ID: 11196511 [TBL] [Abstract][Full Text] [Related]
9. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma. Freedman RR; Girgis R; Mayes MD J Rheumatol; 1999 Nov; 26(11):2386-8. PubMed ID: 10555897 [TBL] [Abstract][Full Text] [Related]
11. Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma. Freedman RR; Girgis R; Mayes MD Lancet; 1999 Aug; 354(9180):739. PubMed ID: 10475187 [TBL] [Abstract][Full Text] [Related]
12. Role of cold and emotional stress in Raynaud's disease and scleroderma. Freedman RR; Ianni P Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474 [TBL] [Abstract][Full Text] [Related]